Reduction of atherosclerosis in mice by inhibition of CD40 signalling
about
Diverse roles of macrophages in atherosclerosis: from inflammatory biology to biomarker discoveryDifferential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cellsCanonical pathway of nuclear factor kappa B activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosisCD40 in coronary artery disease: a matter of macrophages?The role of platelets in the recruitment of leukocytes during vascular diseaseThe role of costimulatory receptors of the tumour necrosis factor receptor family in atherosclerosisThe influence of innate and adaptive immune responses on atherosclerosisCD40 ligand-dependent maturation of human monocyte-derived dendritic cells by activated plateletsTherapeutic approaches in arterial thrombosisOpportunities for the treatment of inflammation in cardiovascular diseaseClinical evidence for anti-inflammatory effects of antiplatelet therapy in patients with atherothrombotic diseaseRelease of biologically active CD154 during collection and storage of platelet concentrates prepared for transfusionCathepsin G activity lowers plasma LDL and reduces atherosclerosisCD40 ligand as a potential biomarker for atherosclerotic instabilityT cell costimulatory and coinhibitory pathways in vascular inflammatory diseasesCytokine-inducible CD40 gene expression in vascular smooth muscle cells is mediated by nuclear factor kappaB and signal transducer and activation of transcription-1Autoreactive HSP60 epitope-specific T-cells in early human atherosclerotic lesionsInterleukin 18 function in atherosclerosis is mediated by the interleukin 18 receptor and the Na-Cl co-transporterVascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms.Dysregulated CD4+ T cells from SLE-susceptible mice are sufficient to accelerate atherosclerosis in LDLr-/- mice.CD40 ligand promotes Mac-1 expression, leukocyte recruitment, and neointima formation after vascular injury.Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/- micePlatelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis.Overexpression of TGF-ß1 in macrophages reduces and stabilizes atherosclerotic plaques in ApoE-deficient miceImpact of glutathione peroxidase-1 deficiency on macrophage foam cell formation and proliferation: implications for atherogenesis.Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets.Oxidative risk for atherothrombotic cardiovascular disease.Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profileInnate and adaptive immunity in atherosclerosis.Toll-like receptor 7 deficiency protects apolipoprotein E-deficient mice from diet-induced atherosclerosisInflammatory and autoimmune reactions in atherosclerosis and vaccine design informatics.CD40L and Its Receptors in Atherothrombosis-An UpdateT-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responsesMechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis.Immunomodulation of atherosclerosis: myth and reality.Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway.CD40 is essential in the upregulation of TRAF proteins and NF-kappaB-dependent proinflammatory gene expression after arterial injuryThe levels of soluble CD40 ligand and C-reactive protein in normal weight, overweight and obese people.The Levels of Inflammatory Markers in the Treatment of Stroke study (LIMITS): inflammatory biomarkers as risk predictors after lacunar stroke.Therapeutic potential of matrix metalloproteinase inhibitors in atherosclerosis.
P2860
Q21285000-D9B5B8B8-FCC8-4D95-BF0B-DE4B2584CE77Q24563090-784CCECA-8025-4161-B756-DE5DD515FE42Q24568066-EA30E78C-86F4-4C30-84A1-7768707D8964Q26752784-FCAB6E83-C651-4DDA-8071-EB7F3B6A1E41Q26801407-0D2A5D27-A894-4AAF-B512-AF0C9979ADCFQ26996707-07A8AF1B-8268-44AC-AA74-D4CFE0E5AD5CQ27000370-9793C274-E702-413F-9355-B1201138C6E6Q28166057-28225D7A-85AA-467F-AF3C-4C716C2C985CQ28187576-AFE18DBB-9ED0-4B84-80F1-20C2A963DF6EQ28192292-AF597052-CCB1-4A44-AB51-23A20C790E77Q28218124-E4649D48-9BB2-4E5F-93C8-1A2F41EDD783Q28221912-505A41F3-E4A9-4103-ABE8-533017CE1C69Q28245234-668131A3-7EFD-4221-A9E7-57E8172042CFQ28288474-C2AE024D-E132-4AB8-BB69-7E303745CA40Q28396774-3A43BAAD-C5BF-4202-950A-7961D790FE3BQ28570672-22C8BFEA-C534-4960-8D21-EB95A8B60CA5Q28710388-D64114BC-1928-48B4-A81A-736168803411Q28771509-5CDD91EE-0DF8-4A7B-B1B5-70FDC6AAB814Q30319434-0F9B5F2E-02A5-4750-9615-118C8B495A71Q30405805-882A1F2B-8D73-48DE-AB44-3544E991FDEEQ30441065-08042C89-BA2B-4E8F-95F2-C7E21A0CACBEQ30444108-6421E178-EAB6-421F-A06B-4883F526FD10Q30497499-F8679F8A-90FA-41A7-AAF0-F64E74EFF3A4Q31075609-0AC7889F-DF4B-44C4-A378-4785F6D610D2Q31132267-DF955098-0FF5-4D10-B6F4-44F4C01C6954Q33183129-5F5B3D2F-10EA-49A1-8B84-EFA55B84915EQ33554184-354ECB29-03D4-43F9-87F2-90F2466E6855Q33656103-67389449-8D9C-42B2-A85E-EA74896A9D78Q33659705-E18E63C2-4046-434A-9205-31EF0A336B3BQ33678336-CEFB83B2-1866-43E7-921F-10D33DC6FBD1Q33805176-97C27B56-9A31-4EFF-94B3-D45C1253014CQ33814059-82E9465C-2607-4043-8D82-54EA128168AEQ33819043-6BD2203C-A762-433A-83C6-4E6B0D0ECF6EQ33835268-036BF003-9AEA-47A1-B29A-2E63886F0790Q33890414-26BC67D8-526F-4358-8D4D-9DC33611F113Q33903180-33CBFDA2-BF09-49CD-B212-AFCC4546784EQ34005419-1C2C78EC-8E23-4207-9109-FDD81D0A587FQ34020389-8B956345-25D2-4646-A44B-275E113E0083Q34054032-B9FFA9BD-6FF8-4CB4-B220-E55A8AF85EB0Q34074837-C298EBE0-D418-4EFD-B9FD-6864FB4313A3
P2860
Reduction of atherosclerosis in mice by inhibition of CD40 signalling
description
1998 nî lūn-bûn
@nan
1998 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Reduction of atherosclerosis in mice by inhibition of CD40 signalling
@ast
Reduction of atherosclerosis in mice by inhibition of CD40 signalling
@en
Reduction of atherosclerosis in mice by inhibition of CD40 signalling
@en-gb
Reduction of atherosclerosis in mice by inhibition of CD40 signalling
@nl
type
label
Reduction of atherosclerosis in mice by inhibition of CD40 signalling
@ast
Reduction of atherosclerosis in mice by inhibition of CD40 signalling
@en
Reduction of atherosclerosis in mice by inhibition of CD40 signalling
@en-gb
Reduction of atherosclerosis in mice by inhibition of CD40 signalling
@nl
prefLabel
Reduction of atherosclerosis in mice by inhibition of CD40 signalling
@ast
Reduction of atherosclerosis in mice by inhibition of CD40 signalling
@en
Reduction of atherosclerosis in mice by inhibition of CD40 signalling
@en-gb
Reduction of atherosclerosis in mice by inhibition of CD40 signalling
@nl
P2093
P2860
P3181
P356
P1433
P1476
Reduction of atherosclerosis in mice by inhibition of CD40 signalling
@en
P2093
P2860
P2888
P3181
P356
10.1038/28204
P407
P577
1998-07-09T00:00:00Z
P6179
1029026219